These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3114885)

  • 1. Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator.
    Goldhaber SZ; Markis JE; Kessler CM; Meyerovitz MF; Kim D; Vauchan DE; Selwyn AP; Loscalzo J; Dawley DL; Sharma GV
    Semin Thromb Hemost; 1987 Apr; 13(2):171-7. PubMed ID: 3114885
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 3. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The thrombolytic treatment of acute and subacute recurrent pulmonary embolism with recombinant tissue plasminogen activator].
    Tiede N; Kasper W; Geibel A; Bassenge D; Langenstein B; Meinertz T; Just H
    Dtsch Med Wochenschr; 1990 Nov; 115(45):1699-704. PubMed ID: 2121453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute pulmonary embolism].
    Meissner E; Niedermeyer J; Fabel H
    Z Kardiol; 1993; 82 Suppl 2():3-12. PubMed ID: 8328207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syncope: a rare presentation of massive pulmonary embolism in a previously healthy girl.
    Ronco R; Catalan J; Salgado C; Vogel A
    Pediatr Emerg Care; 2010 Apr; 26(4):287-9. PubMed ID: 20386413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response.
    Deitcher SR; Lucore CL; Eisenberg PR
    Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
    Vaughan DE; Goldhaber SZ; Kim J; Loscalzo J
    Circulation; 1987 Jun; 75(6):1200-3. PubMed ID: 3105914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoteplase in acute massive pulmonary thromboembolism.
    Tebbe U; Bramlage P; Graf A; Lechleitner P; Bode C; Riess FC; Clemens N; Al-Rawi Y; Konstantinides S; Goldhaber SZ
    Thromb Haemost; 2009 Mar; 101(3):557-62. PubMed ID: 19277420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Randomized double-blind study comparing tissue-type plasminogen activator with placebo in acute myocardial infarct].
    Bleifeld W; Verstraete M; Brower RW; Collen D; Dunning AJ; Lubsen J; Michel PL; Schofer J; Vanhaecke J; Van de Werf F
    Klin Wochenschr; 1988; 66 Suppl 12():86-92. PubMed ID: 3126349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
    François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
    Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic therapy of pulmonary artery embolism in early pregnancy with recombinant tissue-type plasminogen activator].
    Seifried E; Gabelmann A; Ellbrück D; Schmidt A
    Geburtshilfe Frauenheilkd; 1991 Aug; 51(8):655-8. PubMed ID: 1657684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lysis therapy with rt-PA in fulminant pulmonary embolism].
    Popp J; Geiger R
    Dtsch Med Wochenschr; 1990 Jun; 115(24):958-9. PubMed ID: 2113454
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute pulmonary embolism. Aggressive therapy with anticoagulants and thrombolytics.
    Handler JA; Feied CF
    Postgrad Med; 1995 Jan; 97(1):61-2, 65-8, 71-2. PubMed ID: 7816717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective administration of recombinant tissue plasminogen activator (rt-PA) during resuscitation of a post partum patient with massive pulmonary embolism.
    Cyrkowicz A; Bajorek M; Nytko J; Solarz W; Weryński W; Orczyk K
    Zentralbl Gynakol; 1999; 121(8):396-8. PubMed ID: 10486883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.
    Haire WD
    Curr Hematol Rep; 2003 Sep; 2(5):405-6. PubMed ID: 12932312
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of successful thrombolysis by recombinant tissue plasminogen activator for postoperative pulmonary thromboembolism].
    Inoue C; Yano T; Tashiro H; Terasaki H
    Masui; 2002 Feb; 51(2):199-202. PubMed ID: 11889794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of recombinant human tissue-type plasminogen activator in the treatment of acute pulmonary thromboembolism.
    Yamasawa F; Okada Y; Asano K; Mori M; Fujita H; Hasegawa N; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Intern Med; 1992 Jul; 31(7):885-8. PubMed ID: 1450496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.